|
GB1479268A
(en)
|
1973-07-05 |
1977-07-13 |
Beecham Group Ltd |
Pharmaceutical compositions
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
CH596313A5
(enExample)
|
1975-05-30 |
1978-03-15 |
Battelle Memorial Institute |
|
|
US4414147A
(en)
|
1981-04-17 |
1983-11-08 |
Massachusetts Institute Of Technology |
Methods of decreasing the hydrophobicity of fibroblast and other interferons
|
|
US5675941A
(en)
|
1983-12-09 |
1997-10-14 |
Dykmans; Maximiliaan J. |
Method and apparatus for constructing prestressed structures utilizing a membrane and floating dome assembly
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
JP2524586B2
(ja)
|
1985-06-26 |
1996-08-14 |
シタス コーポレイション |
ポリマ−接合を利用する医薬組成物用蛋白質の可溶化
|
|
US6004548A
(en)
|
1985-08-23 |
1999-12-21 |
Amgen, Inc. |
Analogs of pluripotent granulocyte colony-stimulating factor
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
NZ229098A
(en)
|
1988-05-13 |
1992-10-28 |
Amgen Inc |
(bg-csf) bovine granulocyte colony stimulating factor, recombinant methods and pharmaceuticals
|
|
US5218092A
(en)
|
1988-09-29 |
1993-06-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
|
|
US6166183A
(en)
|
1992-11-30 |
2000-12-26 |
Kirin-Amgen, Inc. |
Chemically-modified G-CSF
|
|
WO1990006952A1
(fr)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Facteur de stimulation de colonies de granulocytes modifies chimiquement
|
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
US5399345A
(en)
|
1990-05-08 |
1995-03-21 |
Boehringer Mannheim, Gmbh |
Muteins of the granulocyte colony stimulating factor
|
|
DE4014750A1
(de)
|
1990-05-08 |
1991-11-14 |
Boehringer Mannheim Gmbh |
Muteine des granulozyten-stimulierenden faktors (g-csf)
|
|
US6565841B1
(en)
|
1991-03-15 |
2003-05-20 |
Amgen, Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
DE4126983A1
(de)
*
|
1991-08-15 |
1993-02-18 |
Boehringer Mannheim Gmbh |
Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
|
|
WO1994001483A1
(en)
|
1992-07-02 |
1994-01-20 |
Collagen Corporation |
Biocompatible polymer conjugates
|
|
AU5098193A
(en)
|
1992-09-01 |
1994-03-29 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
|
WO1994028024A1
(en)
|
1993-06-01 |
1994-12-08 |
Enzon, Inc. |
Carbohydrate-modified polymer conjugates with erythropoietic activity
|
|
US5874075A
(en)
|
1993-10-06 |
1999-02-23 |
Amgen Inc. |
Stable protein: phospholipid compositions and methods
|
|
DE69521880T2
(de)
|
1994-02-08 |
2002-01-03 |
Amgen Inc., Thousand Oaks |
Orales verabreichungssystem von chemischmodifizierten proteinen g-csf
|
|
ES2312166T3
(es)
|
1994-02-23 |
2009-02-16 |
Kyowa Hakko Kogyo Co., Ltd |
Acelerador del crecimiento plaquetario.
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
CA2242488A1
(en)
|
1996-02-15 |
1997-08-21 |
Novo Nordisk A/S |
Conjugation of polypeptides
|
|
DE69823046T2
(de)
|
1997-01-16 |
2005-03-31 |
Neose Technologies, Inc. |
Praktische in vitro sialylierung von rekombinanten glykpproteinen
|
|
ATE469166T1
(de)
|
1997-06-06 |
2010-06-15 |
Kyowa Hakko Kirin Co Ltd |
Chemisch modifizierte polypeptide
|
|
US6540672B1
(en)
*
|
1998-12-09 |
2003-04-01 |
Novo Nordisk A/S |
Medical system and a method of controlling the system for use by a patient for medical self treatment
|
|
FR2796071B1
(fr)
|
1999-07-08 |
2001-09-07 |
Hoechst Marion Roussel Inc |
Procede de purification de facteur de stimulation de colonies de granulocytes
|
|
US6555660B2
(en)
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
|
IL150153A0
(en)
|
2000-01-10 |
2002-12-01 |
Maxygen Holdings Ltd |
G-csf conjugates
|
|
JP4683810B2
(ja)
*
|
2000-02-29 |
2011-05-18 |
中外製薬株式会社 |
長期安定化製剤
|
|
WO2001088117A2
(en)
|
2000-05-12 |
2001-11-22 |
Neose Technologies, Inc. |
In vitro fucosylation recombinant glycopeptides
|
|
CZ304855B6
(cs)
|
2000-05-15 |
2014-12-10 |
F. Hoffmann-La Roche Ag |
Kapalná farmaceutická kompozice obsahující pegylovaný lidský erythropoetin, způsob její přípravy, léčivo pro léčení chorob korelujících s anemií při chronickém renálním selhání a zařízení s jejím obsahem
|
|
ES2290142T3
(es)
|
2000-05-16 |
2008-02-16 |
Bolder Biotechnology, Inc. |
Metodos para replegamiento de proteinas que contiene residuos de cisteina libre.
|
|
KR100396983B1
(ko)
|
2000-07-29 |
2003-09-02 |
이강춘 |
고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
|
|
WO2002011753A1
(en)
|
2000-08-04 |
2002-02-14 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
AU2001282607B2
(en)
|
2000-09-01 |
2006-08-17 |
Chugai Seiyaku Kabushiki Kaisha |
Solution preparations stabilized over long time
|
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
|
HK1080090B
(zh)
|
2001-10-10 |
2012-12-14 |
诺和诺德公司 |
肽的重构和糖缀合的方法
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
SI21102A
(sl)
|
2001-12-19 |
2003-06-30 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika
|
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
|
SI21273A
(sl)
|
2002-07-31 |
2004-02-29 |
LEK farmacevtska dru�ba d.d. |
Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
|
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
|
CA2534418A1
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and g-csf
|
|
DE10348550A1
(de)
|
2003-10-20 |
2005-06-16 |
Hexal Biotech Forschungsgmbh |
Stabile wässrige G-CSF-haltige Zusammensetzungen
|
|
US7585496B2
(en)
|
2003-11-04 |
2009-09-08 |
Lek Pharmaceuticals D.D. |
Stable pharmaceutical composition granulocyte-colony stimulating factor
|
|
AU2004296855B2
(en)
|
2003-12-03 |
2011-01-06 |
Ratiopharm Gmbh |
Glycopegylated Granulocyte Colony Stimulating Factor
|
|
JP5743368B2
(ja)
*
|
2004-01-08 |
2015-07-01 |
ラショファーム ゲーエムベーハー |
ペプチドのｏ結合型グリコシル化
|
|
EP2279752A3
(en)
|
2004-03-11 |
2011-08-24 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation
|
|
EP1725589A1
(en)
|
2004-03-11 |
2006-11-29 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
|
|
DE102004036909B4
(de)
|
2004-07-29 |
2007-04-05 |
Infineon Technologies Ag |
Halbleiterbasisbauteil mit Verdrahtungssubstrat und Zwischenverdrahtungsplatte für einen Halbleiterbauteilstapel sowie Verfahren zu deren Herstellung
|
|
ES2449195T3
(es)
*
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
|
US20080171857A1
(en)
|
2005-03-17 |
2008-07-17 |
Uma Devi Komath |
Process for the Purification of Recombinant Granulocyte-Colony Stimulating Factor
|
|
BRPI0611221A2
(pt)
*
|
2005-06-01 |
2010-08-24 |
Maxygen Holdings Ltd |
polipeptÍdeos de g-csf peguilados e mÉtodos de produÇço dos mesmos
|
|
EP1762250A1
(en)
|
2005-09-12 |
2007-03-14 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
|
|
DE202006020194U1
(de)
|
2006-03-01 |
2007-12-06 |
Bioceuticals Arzneimittel Ag |
G-CSF-Flüssigformulierung
|
|
ITMI20061624A1
(it)
|
2006-08-11 |
2008-02-12 |
Bioker Srl |
Mono-coniugati sito-specifici di g-csf
|
|
NZ580030A
(en)
|
2007-04-03 |
2012-06-29 |
Biogenerix Ag |
Methods of treatment using glycopegylated g-csf
|
|
US8207112B2
(en)
*
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|